drugset / Trial / NCT03363633

Perforator Vein Injection for Symptomatic Venous Disease

NCT03363633

RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective of this study is to compare two treatment strategies for symptomatic venous stasis disease with and without venous ulcer. These treatments are compression therapy alone vs. sclerotherapy of refluxing perforating veins with compression.

Timeline

Start
2010-03
Primary completion
2010-10-01
Completion
2010-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Tetradecyl Sulfate Unknown Intravenous

Indications